Business Wire- ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes.
Recent Posts
A (Dog’s) Day in the Life: Work from Home Edition
My name is Denali. I’m one of the regular Doggie Day “coworkers” at UPMC Enterprises. However, it has been a couple months since my mom started working from home full-time.
Read More →
Meet the Executive: David Gibson, Chief Financial Officer of UPMC Enterprises
David Gibson was named Chief Financial Officer of UPMC Enterprises in November 2019. As CFO, …
Read More →